Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 11/20 | 0.44 |
| ▸ | NPC1 | O15118 | 8/20 | 0.44 |
| ▸ | MAPT | P10636 | 6/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | APP | P05067 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | MMP9 | P14780 | 2/20 | 0.44 |
| ▸ | MMP8 | P22894 | 2/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 3/20 | 0.41 |
| ▸ | RELA | Q04206 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22178073 | 1.00 | RAB9A (0.44) | RAB9ANPC1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL22178072 | 0.98 | RAB9A (0.46) | RAB9ANPC1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL22178122 | 0.96 | APP (0.49) | RAB9ANPC1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL22178116 | 0.96 | RAB9A (0.41) | RAB9ANPC1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL22178567 | 0.94 | RAB9A (0.41) | RAB9ANPC1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL22178074 | 0.94 | RAB9A (0.41) | RAB9ANPC1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL22178087 | 0.94 | RAB9A (0.43) | RAB9ANPC1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL22178218 | 0.93 | ALOX5 (0.42) | RAB9ANPC1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL22178066 | 0.93 | RAB9A (0.42) | RAB9ANPC1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL22177839 | 0.93 | APP (0.48) | RAB9ANPC1MAPTKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11518769-B2 | Heterocyclic compounds and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2022-12-06 | — | — | US | disclosed |
| US-20200207754-A1 | NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200207754-A1 | NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CRY1, CRY2, CYP1A1 | RAB9A 2411/4885NPC1 2337/4885MAPT 1997/4885 |
| US-11518769-B2 | Heterocyclic compounds and organic light emitting device using the same | CRY1, CYP1A1, CRY2 | RAB9A 2545/4885NPC1 2044/4885MAPT 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.